GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Sanofi CEO: Alnylam deal extension of Genzyme philosophy

Mon 13 Jan 14 | 10:10 AM ET
Chris Viehbacher, Sanofi CEO, discusses the $700 million deal Sanofi struck with Alnylam and the company's growth into the treatment of genetic diseases.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Brazil and India doing well: WPP CEO
Fri 25 Apr 14 | 02:05 AM ET
Latest Videos
Sterling strength 'biggest short-term issue': WPP CEO
Fri 25 Apr 14 | 02:05 AM ET
Latest Videos
Mexico 'courageous' in opening up energy sector: Pro
Fri 25 Apr 14 | 01:45 AM ET
Latest Videos
All eyes on Mexico's energy sector
Fri 25 Apr 14 | 01:45 AM ET
Go
Displaying results for: Latest Video | US